| Induction of apoptosis in malignant and camptothecin-resistant human cells. | |
| | |
MedLine Citation:
|
PMID: 8993507 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Flow cytometry studies demonstrate that androgen-independent human prostate carcinoma DU-145 cells are arrested at the G1-phase of the cell cycle in the presence of suramin, but they die by apoptosis in the presence of 9-nitrocamptothecin (9NC). The addition of cytostatic concentrations of suramin increases the apoptotic action of 9NC on DU-145 cells, and induces apoptosis in 9NC-resistant DU-145/RC cells that were derived from the parental DU-145 cells by continuous exposure to progressively increased concentrations of 9NC. In addition, the topoisomerase II-directed drug etoposide exerts more extensive apoptotic action on DU-145/RC than DU-145 cells. Increased resistance of DU-145 cells to 9 NC and collaterally increased sensitivity to etoposide and suramin appear to correlate with alterations in the structure rather than synthesis of topoisomerases and possibly with specific cellular proteins that regulate apoptosis. The results suggest that etoposide and suramin may be successful alternative treatments for 9NC-resistant androgen-independent prostate cancer. |
| | |
Authors:
|
D Chatterjee; J H Wyche; P Pantazis |
Related Documents
:
|
18980187 - Development of a stable dual cell-line gfp expression system to study estrogenic endocr... 20170107 - Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type p... 10715537 - A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen ef... 1384957 - Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. 7666547 - Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency vir... 6650117 - Volume changes during mitosis in pancreatic acinar cells of the rat. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Annals of the New York Academy of Sciences Volume: 803 ISSN: 0077-8923 ISO Abbreviation: Ann. N. Y. Acad. Sci. Publication Date: 1996 Dec |
Date Detail:
|
Created Date: 1997-01-29 Completed Date: 1997-01-29 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7506858 Medline TA: Ann N Y Acad Sci Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 143-56 Citation Subset: IM |
Affiliation:
|
Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, Rhode Island, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Androgens
/
pharmacology Antineoplastic Agents / pharmacology* Apoptosis / drug effects* Camptothecin / analogs & derivatives*, pharmacology Cell Cycle / drug effects Cell Cycle Proteins / metabolism DNA Topoisomerases, Type I / metabolism Drug Interactions Drug Resistance Enzyme Inhibitors / pharmacology Etoposide / pharmacology Humans Male Prostatic Neoplasms Proto-Oncogene Proteins / metabolism Proto-Oncogene Proteins c-bcl-2 / metabolism Suramin / pharmacology Tumor Cells, Cultured bcl-2-Associated X Protein |
| Chemical | |
Reg. No./Substance:
|
0/Androgens; 0/Antineoplastic Agents; 0/Cell Cycle Proteins; 0/Enzyme Inhibitors; 0/Proto-Oncogene Proteins; 0/Proto-Oncogene Proteins c-bcl-2; 0/bcl-2-Associated X Protein; 104195-61-1/9-nitrocamptothecin; 145-63-1/Suramin; 33419-42-0/Etoposide; 7689-03-4/Camptothecin; EC 5.99.1.2/DNA Topoisomerases, Type I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of camptothecin on topoisomerase I catalysis.
Next Document: Pharmacokinetics of camptothecins administered orally.